Document is current
Any future updates will be listed below
-
Authors
Mehta, Gaurav A.
Parker, Joel S.
Silva, Grace O.
Hoadley, Katherine A.
Perou, Charles M.
Gatza, Michael L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R00-CA166228, P50-CA58223-09A1, R01-CA148761-04)
V Foundation for Cancer Research (V2016-013)
New Jersey Health Foundation (PC5216)
Susan G. Komen for the Cure
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 16 November 2016
Accepted: 2 February 2017
First Online: 7 February 2017
Compliance with ethical standards
:
: CM.P. is an equity stock holder and board of director member of BioClassifier LLC and GeneCentric Diagnostics. C.M.P. is also listed as an inventor on a patent application for the PAM50 molecular assay. J.S.P. is also listed as an inventor on a patent application for the PAM50 molecular assay. All other authors declare no conflicts of interest.
